Skip to content

Rate of Malignant Transformation and Clinical Characteristics Among an Oral Lichen Planus Cohort: a Retrospective Center Experience

Observational Study of an OLP Patients Cohort: Characteristics, Comorbidities, Risk Factors for Malignant Transformation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06934863
Acronym
LPO_CMR
Enrollment
300
Registered
2025-04-18
Start date
2024-01-31
Completion date
2029-01-31
Last updated
2026-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Carcinoma, Oral Carcinoma in Situ, Oral Lichen Planus

Keywords

Oral Lichen Planus, Malignant Transformation, Oral Carcinoma, Oral Dysplasia

Brief summary

The main objective of this paper will be to evaluate the rate of malignant transformation among a cohort of patients affected by oral lichen planus with long-term follow-up. Secondary aims will be to study and describe the characteristics of these patients to identify potential risk factors for malignant transformation, and to evaluate the therapeutic effects and features to OLP drgus.

Detailed description

Oral Lichen Planus (OLP) is a chronic inflammatory mucocutaneous disease of unknown etiology, primarily affecting the oral mucosa. Global prevalence ranges from 1.01% to 3%, with an estimated 1.43% prevalence in Europe. Although OLP can affect the scalp, nails, and skin, it most commonly manifests in the oral cavity. The disease primarily involves the stratified squamous epithelium of the mouth, and while its precise cause remains unclear, it is thought to result from a T-cell-mediated autoimmune response, triggered by microbial agents, chemicals, stress, or viral infections. T cells directly attack keratinocytes, causing epithelial damage, with both specific (T-cell activity) and nonspecific mechanisms (MMPs, chemokines, and mast cells) contributing to disease progression. CD8+ and CD4+ T cells and Langerhans cells play key roles in antigen presentation, while Matrix Metalloproteinases (MMPs) and their inhibitors (TIMPs) are involved in the breakdown of the basement membrane, leading to keratinocyte destruction. The main objective of this paper will be to evaluate the rate of malignant transformation among a cohort of patients affected by oral lichen planus with long-term follow-up. Secondary aims will be to study and describe the characteristics of these patients to identify potential risk factors for malignant transformation, and to evaluate the therapeutic effects and features to OLP drgus. Also, dental and periodontal status will be evaluated based on charts and charting data.

Interventions

None listed

Sponsors

Catholic University of the Sacred Heart
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Clinical-histological diagnosis of Oral lichen planus * Patients who gave consensus to personal data treatment * Minimum 6 months follow-up

Exclusion criteria

* Patients who did not give consensus to personal data treatment * Oral lichenoid lesions * Patients with anamnesis of hematopoietic stem cells transplant * Patients with a OSCC at the first histological examination (i.e., namely: also OSCC patients with a OLP background were excluded)

Design outcomes

Primary

MeasureTime frameDescription
Number of Oral CarcinomasFrom January 2024 to January 2028Number of cases that will be histologically diagnosed as Oral Carcinomas. This outcome will be expressed as a dichotomous variable (i.e., yes/no).

Countries

Italy

Contacts

CONTACTCarlo Lajolo Associate Professor, DDS, MD, PhD
carlo.lajolo@unicatt.it3356078354
CONTACTCarlo Lajolo Associate Professor, MD, DDS, PhD
carlo.lajolo@unicatt.it3356078354

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 15, 2026